Table 1.
Author | outcome |
---|---|
Chatterjee (1980) [24] | 1-year patient survival 86% 1-year graft survival 67% mortality 1st year 13% Increased sickle cell crisis |
Barber et al. (1987) [22] | 1-year graft survival 25% Crises in 75% |
Miner et al. (1987) [27] | Recurrent nephropathy |
Chatterjee (1987) [25] | 1-year patient survival 88% 1-year graft survival 82% in live, 62% in cadaveric, Increased sickle cell crisis |
Montgomery et al. (1994) [23] | 1-year patient and graft survival 100% Increased sickle cell crisis |
Warady and Sullivan (1998) [29] | 1-year graft survival 89% 2-year graft survival 71% Patient survival 89% |
Ojo et al. (1999) [31] | Delayed function 24% Acute rejection 26% 1-year graft survival 78% 3-year graft survival 46% 1-year patient survival 78% 3-year patient survival 59% Median survival 33 months Recurrent nephropathy |
Bleyer et al. (2001) [28] | 1-year patient survival 90.5% 3-year patient survival 75.0% 1-year graft 82.5% 3-year graft survival 53.8% |
Abbott et al. (2002) [8] | Risk of mortality same as in transplanted non sickle cell disease |
O'Rourke et al. (2008) [32] | Recurrent allograft dysfunction from vascular congestion and tubular necrosis |
Scheinman (2009) [33] | 10-year patient survival 56% |
Kim et al. (2011) [34] | Intragraft sickle cell vasoocclusive crisis as a cause of early allograft loss |